MS patients experience decrease in life expectancy: Study.
David Kaufman, ScD, of the Slone Epidemiology Center at Boston University, is the lead author. The work is the result of a collaboration between the investigators at BU and their colleagues at University of California San Francisco, the University of Alabama, Heinrich Heine University in Dusseldorf, Care-Safe LLC, a consulting firm and the sponsor of the research, Bayer HealthCare Pharmaceuticals.
The investigators used health insurance claims data to identify a series of patients with MS and a comparison group of individuals from the same health plans who did not have MS.
A total of 30,402 MS patients and 89,818 non-MS subjects who were in the OptumInsight Research (OIR) database from 1996-2009 were included in the study. Data on deaths was obtained from government databases of death records. Annual mortality rates were 899/100,000 in MS patients and 446/100,000 in comparators.
The median lifespan was 6 years less among the MS patients than among the non-MS group.
While early mortality due to MS is relatively rare, the new data confirm that compared to the general population, MS patients in the US do experience a decrease in life expectancy.
The study has been published in the journal Multiple Sclerosis and Related Disorders. ( ANI )
Copyright 2014 aninews.in All rights reserved. Provided by Syndigate.info , an Albawaba.com company
|Printer friendly Cite/link Email Feedback|
|Publication:||Asian News International|
|Date:||Jan 22, 2014|
|Previous Article:||Anti-swine flu vaccination ups risk of narcolepsy in young adults.|
|Next Article:||Do you want to cut heart failure risk? Exercise more and sit less.|